Olinding, Lolita M.
HRN: 05-06-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/06/2022
06/13/2022
IVT
600mg
Q8hrs
Infected Stump
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes